Ondansetron-Induced Anaphylactic Shock: An In-Depth Analysis of a Rare Adverse Event.

anaphylaxis anesthesia histamine mrgprx2 ondansetron

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2023
Historique:
accepted: 03 08 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

Ondansetron, a drug predominantly employed in most general anesthesia cases, is critical for mitigating postoperative nausea and vomiting prompted by anesthetics. Although infrequent side effects such as serotonin syndrome are recognized, the drug is generally acknowledged for its safety. Nonetheless, some reports showed cases of anaphylactic shock associated with ondansetron. In this context, we have meticulously analyzed an anaphylactic case triggered by ondansetron that we encountered. Our deep-dive investigation suggests that the reaction might not be a traditional type I allergic reaction, typically associated with the drug. Instead, we present the possibility that the response could be mediated through Mas-related G protein-coupled receptor X2 (MRGPRX2), a divergent pathway leading to comparatively milder symptoms of anaphylaxis. In addition to the crucial role of adrenaline in unstable hemodynamics, our case highlights the effective use of antihistamines in rapidly managing such reactions. This finding suggests a need to further examine the safety profiles of common drugs like ondansetron and the potential involvement of MRGPRX2 in drug-induced hypersensitivity reactions.

Identifiants

pubmed: 37664335
doi: 10.7759/cureus.42894
pmc: PMC10474905
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e42894

Informations de copyright

Copyright © 2023, Suzuki et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Anesth. 2021 Dec;35(6):778-793
pubmed: 34651257
J Allergy Clin Immunol Pract. 2019 Mar;7(3):998-1003
pubmed: 30315997
Int J Mol Sci. 2019 Oct 23;20(21):
pubmed: 31652731
Nature. 2021 Dec;600(7887):164-169
pubmed: 34789875
Sci Rep. 2018 Aug 2;8(1):11628
pubmed: 30072729
Nat Chem Biol. 2017 May;13(5):529-536
pubmed: 28288109
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898
pubmed: 34278794
Anesthesiology. 2015 Jan;122(1):39-45
pubmed: 25405395
Eur J Pharmacol. 2020 Jul 5;878:173104
pubmed: 32320700
Clin Case Rep. 2021 May 05;9(5):e04110
pubmed: 34026152
Neurosci Lett. 2021 Apr 23;751:135746
pubmed: 33610674
Arch Intern Med. 2001 Oct 8;161(18):2263
pubmed: 11575988
Br J Anaesth. 2009 Feb;102(2):285-6
pubmed: 19151059

Auteurs

Yasuyuki Suzuki (Y)

Anesthesiology, Saiseikai Matsuyama Hospital, Matsuyama, JPN.

Shuang Liu (S)

Pharmacology, Ehime University Graduate School of Medicine, Toon, JPN.

Mari Iwata (M)

Dermatology, Ehime Prefectural Central Hospital, Matsuyama, JPN.

Hideshi Yamamoto (H)

General Surgery, Saiseikai Matsuyama Hospital, Matsuyama, JPN.

Katsuko Nishida (K)

Anesthesiology, Saiseikai Matsuyama Hospital, Matsuyama, JPN.

Classifications MeSH